It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The Mycobacterium tuberculosis complex (MTBC) members display different host-specificities and virulence phenotypes. Here, we have performed a comprehensive RNAseq and methylome analysis of the main clades of the MTBC and discovered unique transcriptional profiles. The majority of genes differentially expressed between the clades encode proteins involved in host interaction and metabolic functions. A significant fraction of changes in gene expression can be explained by positive selection on single mutations that either create or disrupt transcriptional start sites (TSS). Furthermore, we show that clinical strains have different methyltransferases inactivated and thus different methylation patterns. Under the tested conditions, differential methylation has a minor direct role on transcriptomic differences between strains. However, disruption of a methyltransferase in one clinical strain revealed important expression differences suggesting indirect mechanisms of expression regulation. Our study demonstrates that variation in transcriptional profiles are mainly due to TSS mutations and have likely evolved due to differences in host characteristics.
A variety of biological differences exist between strains and phylogenetic lineages in the Mycobacterium tuberculosis complex (MTBC). Here, the authors perform RNAseq and methylome analysis of the main clades of the MTBC and show variation in transcriptional profiles is mainly due to mutations in transcriptional start sites.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 Instituto de Biología Integrativa de Sistemas-I2SysBio, Unidad Mixta “Infección y Salud Pública” FISABIO-CSISP/Universidad de Valencia, Valencia, Spain; Instituto de Biomedicina de Valencia, IBV-CSIC, Valencia, Spain (GRID:grid.466828.6) (ISNI:0000 0004 1793 8484)
2 Albert Einstein College of Medicine, Department of Microbiology and Immunology and Department of Molecular Genetics, New York, USA (GRID:grid.251993.5) (ISNI:0000000121791997)
3 Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK (GRID:grid.10306.34) (ISNI:0000 0004 0606 5382); Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam (GRID:grid.412433.3) (ISNI:0000 0004 0429 6814)
4 Instituto de Biología Integrativa de Sistemas-I2SysBio, Unidad Mixta “Infección y Salud Pública” FISABIO-CSISP/Universidad de Valencia, Valencia, Spain (GRID:grid.412433.3); CIBER en Epidemiología y Salud Pública, Valencia, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427)
5 The Francis Crick Institute, London, UK (GRID:grid.451388.3) (ISNI:0000 0004 1795 1830)
6 Swiss Tropical and Public Health Institute, Basel, Switzerland (GRID:grid.416786.a) (ISNI:0000 0004 0587 0574); University of Basel, Basel, Switzerland (GRID:grid.6612.3) (ISNI:0000 0004 1937 0642)
7 University of Cambridge, Department of Veterinary Medicine, Cambiddge, UK (GRID:grid.5335.0) (ISNI:0000000121885934)
8 London School of Hygiene and Tropical Medicine, Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London, UK (GRID:grid.8991.9) (ISNI:0000 0004 0425 469X)
9 Instituto de Biomedicina de Valencia, IBV-CSIC, Valencia, Spain (GRID:grid.466828.6) (ISNI:0000 0004 1793 8484); CIBER en Epidemiología y Salud Pública, Valencia, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427)